Gc Cell Corp. (144510)

Overview

GC Cell Corporation, initially established as Green Cross Lab Cell Corporation, has made a significant impact in the field of cell therapy since its foundation in 2011. With its base in Yongin, South Korea, the company has dedicated itself to the development of innovative cell therapy products, contributing to the advancement of regenerative medicine. In November 2021, it underwent a strategic rebranding to GC Cell Corporation, reflecting its broadened vision and commitment to its core operations. The company's expertise spans beyond product development to encompass comprehensive services that support the cell therapy sector, including cell banking, sample inspection, clinical trials, and bio logistics services. This holistic approach ensures that GC Cell Corporation not only leads in product innovation but also in facilitating the delivery and application of cell therapies, promoting a higher standard of care in medical practices.

Products and Services

• Cell Therapy Products - As the cornerstone of GC Cell Corporation's offerings, its cell therapy products are at the forefront of regenerative medicine. These therapeutic solutions are designed to repair, replace, or restore biological functions that have been compromised due to disease or injury. Their development is driven by cutting-edge research and a commitment to quality and efficacy.
• Cell Banking - GC Cell Corporation provides secure and reliable cell banking services, offering clients the ability to store biological materials under optimal conditions. This service is indispensable for preserving the genetic and cellular integrity for future therapeutic or research applications, ensuring that they remain viable over long periods.
• Sample Inspection - Ensuring the safety and quality of cellular materials is critical. GC Cell Corporation offers comprehensive sample inspection services to verify the viability, purity, and potency of cell therapy products. This rigorous quality control process is vital for maintaining high standards in cell therapy treatments and research endeavors.
• Clinical Trial Management - Leveraging its in-depth expertise in cell therapy, GC Cell Corporation provides end-to-end clinical trial management services. These services encompass design, implementation, monitoring, and analysis of clinical studies, facilitating the development and eventual market approval of innovative cell therapy products.
• Bio Logistics Services - Recognizing the sensitive nature of biological materials, GC Cell Corporation offers specialized bio logistics services. This encompasses the secure transportation and handling of cellular therapies and related samples. Their logistics solutions are designed to ensure the integrity and timely delivery of these materials, crucial for both clinical and research purposes.